Icon

YONSA (nda210308)- (125MG)

ABIRATERONE ACETATE SUN PHARM
125MG
Yes Yes
2034-May-20 Expired
None None
None No
YONSA is a CYP17 inhibitor indicated in combination with methylprednisolone for the treatment of patients with metastatic castrationresistant prostate cancer (CRPC).
0 0 0
Total Other Developers 1
Drugs with Suitability No
125MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.